| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/28/2003 | CA2406303A1 Episulfide compound, method for producing the same and optical product comprising same |
| 05/27/2003 | US6569868 Imidazoly 2-indolinones as anticarcinogenic, -diabetic, -arthritic, -proliferative and inflammatory agents; fibrosis; autoimmune disorder, angiogenesis, restenosis, psoriasis, osteoarthritis and rheumatoid arthritis |
| 05/27/2003 | US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances |
| 05/27/2003 | US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity |
| 05/27/2003 | CA2268847C Substituted oximes derivatives useful as neurokinin antagonists |
| 05/27/2003 | CA2209391C New heterocyclic biaryl compounds and their use in human or veterinary medicine and in cosmetics |
| 05/27/2003 | CA2104297C 4-sulfanimide-quinoline nmda antagonists |
| 05/22/2003 | WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 05/22/2003 | WO2003042187A1 Serin protease inhibitors |
| 05/22/2003 | WO2003042181A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 05/22/2003 | WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 05/22/2003 | WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 05/22/2003 | WO2003042174A1 Cannabinoid receptor ligands |
| 05/22/2003 | WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 05/22/2003 | WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors |
| 05/22/2003 | WO2003041658A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds |
| 05/22/2003 | WO2003007883A3 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 05/22/2003 | US20030096852 Inhibiting binding interaction between hGH (human growth hormone) or a mutant thereof and an hGH binding protein or receptor in mammal administering benzimidazole compound |
| 05/22/2003 | US20030096841 For treatment of cancers, heart disease, such as congestive heart failure, osteoporosis, genetic, inflammatory, allergic, and autoimmune diseases |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents |
| 05/22/2003 | US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders |
| 05/22/2003 | US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096737 Caspase inhibitors and uses thereof |
| 05/22/2003 | US20030096138 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes |
| 05/22/2003 | US20030096117 Base structure is a chromene(3,2-a)fluorene ring containing spiro-fused rings; photochromic lenses; large fading rate, less color when deteriorated, and excellent light resistance in the photochromic properties |
| 05/22/2003 | CA2467391A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 05/22/2003 | CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | CA2466440A1 Cannabinoid receptor ligands |
| 05/22/2003 | CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 05/22/2003 | CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | CA2464419A1 Benzimidazoles useful as protein kinase inhibitors |
| 05/22/2003 | CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | CA2464069A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 05/21/2003 | EP1312622A1 Process for the preparation of linear or branched 1,4-cis polybutadiene |
| 05/21/2003 | EP1311502A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders |
| 05/21/2003 | EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/21/2003 | EP1071656B1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same |
| 05/21/2003 | EP1023268B1 Isoquinolines as urokinase inhibitors |
| 05/21/2003 | EP0874827B1 Quinoline derivatives as nk3 antagonists |
| 05/21/2003 | CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 05/21/2003 | CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity |
| 05/21/2003 | CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 05/21/2003 | CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403 |
| 05/21/2003 | CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 05/21/2003 | CN1419452A Synergistic methods and compositions for treating cancer |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 05/21/2003 | CN1109026C Sidechain-beering taxanes like compounds |
| 05/21/2003 | CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof |
| 05/20/2003 | US6566536 Thienylsulphonylamino(thio)carbonyl compounds |
| 05/20/2003 | US6566383 Sulfonyltriazol derivatives and their use for combating micro-organisms |
| 05/20/2003 | US6566380 For therapy of cardiac arrhythmias |
| 05/20/2003 | US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 05/20/2003 | US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/20/2003 | US6566373 For therapy of osteoporosis, periodontitis, and arthritis |
| 05/20/2003 | US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer |
| 05/20/2003 | US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 05/20/2003 | US6566356 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 05/20/2003 | US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 05/20/2003 | CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
| 05/20/2003 | CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers |
| 05/15/2003 | WO2003040256A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 05/15/2003 | WO2003040160A1 Rhodium and iridium complexes |
| 05/15/2003 | WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________ |
| 05/15/2003 | WO2003040131A1 Aminopyrimidines and pyridines |
| 05/15/2003 | WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 05/15/2003 | WO2003040109A2 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040108A1 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003039549A2 Selective antibacterial agents |
| 05/15/2003 | WO2003039547A1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 05/15/2003 | WO2003039529A1 Selective antibacterial agents |
| 05/15/2003 | WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors |
| 05/15/2003 | WO2003007071A3 Novel nonlinear optical compounds and polymers |
| 05/15/2003 | WO2003000692A3 Oxytocin agonists |
| 05/15/2003 | WO2001079173A3 Enamine derivatives as cell adhesion molecules |
| 05/15/2003 | US20030092912 Brain disorders, anticonvulsants, antidepressants, drug abruse |
| 05/15/2003 | US20030092869 Crosslinking; heat resistance, stability |
| 05/15/2003 | US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents |
| 05/15/2003 | US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 05/15/2003 | US20030092733 Chemical intermediate for drugs |
| 05/15/2003 | US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases |
| 05/15/2003 | US20030092728 Antagonists of MCP-1 function and methods of use thereof |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092712 Antiinflammatory agents; rheumatic diseases |
| 05/15/2003 | US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases |
| 05/15/2003 | US20030092698 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 05/15/2003 | US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 05/15/2003 | US20030092677 Glutamate receptor antagonists |
| 05/15/2003 | CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2466143A1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |